Product Code: RP-ID-10265619 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10265619
Market Overview:
Global Anatomic Pathology Market Size study, by Product & Service (Services, Consumables, Instruments) By Application (Disease Diagnostics, Medical Research) By End User (Hospital Laboratories, Clinical Laboratories, Other End Users) and Regional Forecasts 2019-2026
Global Anatomic Pathology Market is valued approximately USD 31.10 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 6.10% over the forecast period 2019-2026. Anatomic pathology or anatomical pathology is a medical field that is involved in the analysis of disease based on the biochemical, macroscopic, microscopic, immunologic and molecular examination of body organs and tissues. The key role of these anatomic pathology is to identify the abnormalities that can assist in diagnoses disease and also to manage treatment. High incidence of cancer and other target diseases and growing focus on personalized medicines are key driving forces of the market growth. According to cancer research organization of UK, in 2018 there were about 17 million new cases of cancer across the globe and this number is estimated to reach 27.5 million new cases by 2040. Furthermore, availability of reimbursement and emerging economies is expected to create significant growth opportunity in the market over the forecast period. However, lack of a skilled professionals impedes the growth of the market over the forecast period of 2019-2026.
The regional analysis of global Anatomic Pathology market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the ease accessibility of the advanced technologies, promptness & affordability of healthcare services coupled with the well-established healthcare infrastructure. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as rising prevalence of chronic diseases and other targeted diseases would create lucrative growth prospects for the Anatomic Pathology market across Asia-Pacific region.
Major market player included in this report are:
F. Hoffman-La Roche Ltd.
Danaher corporation
Thermo Fisher Scientific
BioGenex Laboratories
Hologic, Inc.
Agilent Technologies
Becton, Dickinson and Company
Sakura Finetek USA Inc.
Merck KGaA
Bio SB
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product & Service:
Services
Consumables
Instruments
By Application:
Disease Diagnostics
Medical Research
By End User:
Hospital Laboratories
Clinical Laboratories
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Anatomic Pathology Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Danaher corporation
Thermo Fisher Scientific
BioGenex Laboratories
Hologic, Inc.
Agilent Technologies
Becton, Dickinson and Company
Sakura Finetek USA Inc.
Merck KGaA
Bio SB
Related Reports
Proof of Quality & Reliability
